Cargando…

Co-inhibition of pol θ and HR genes efficiently synergize with cisplatin to suppress cisplatin-resistant lung cancer cells survival

Cisplatin exert its anticancer effect by creating intrastrand and interstrand DNA cross-links which block DNA replication and is a major drug used to treat lung cancer. However, the main obstacle of the efficacy of treatment is drug resistance. Here, we show that expression of translesion synthesis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dai, Chun-Hua, Chen, Ping, Li, Jian, Lan, Tin, Chen, Yong-Chang, Qian, Hai, Chen, Kang, Li, Mei-Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323145/ https://www.ncbi.nlm.nih.gov/pubmed/27533083 http://dx.doi.org/10.18632/oncotarget.11214

Ejemplares similares

Polθ Inhibition: An Anticancer Therapy for HR-Deficient Tumours
por: Barszczewska-Pietraszek, Gabriela, et al.
Publicado: (2022)

Synthetic Lethality Targeting Polθ
por: Drzewiecka, Małgorzata, et al.
Publicado: (2022)

NVP-BEZ235 synergizes cisplatin sensitivity in osteosarcoma
por: Huang, Jin-Cheng, et al.
Publicado: (2017)

Simultaneous inhibition of DNA-PK and Polϴ improves integration efficiency and precision of genome editing
por: Wimberger, Sandra, et al.
Publicado: (2023)

Cisplatin and CCNU synergism in spheroid cell subpopulations.
por: Durand, R. E.
Publicado: (1990)

p53 orchestrates DNA replication restart homeostasis by suppressing mutagenic RAD52 and POLθ pathways
por: Roy, Sunetra, et al.
Publicado: (2018)

Polθ reverse transcribes RNA and promotes RNA-templated DNA repair
por: Chandramouly, Gurushankar, et al.
Publicado: (2021)

Piperlongumine Induces Apoptosis and Synergizes with Cisplatin or Paclitaxel in Human Ovarian Cancer Cells
por: Gong, Li-Hua, et al.
Publicado: (2014)

Polθ is phosphorylated by PLK1 to repair double-strand breaks in mitosis
por: Gelot, Camille, et al.
Publicado: (2023)

Curcumol Synergizes with Cisplatin in Osteosarcoma by Inhibiting M2-like Polarization of Tumor-Associated Macrophages
por: Wang, Jincheng, et al.
Publicado: (2022)

Granulin A Synergizes with Cisplatin to Inhibit the Growth of Human Hepatocellular Carcinoma
por: Qiao, Gan, et al.
Publicado: (2018)

Translesion activity of PrimPol on DNA with cisplatin and DNA–protein cross-links
por: Boldinova, Elizaveta O., et al.
Publicado: (2021)

PARP inhibitors chemopotentiate and synergize with cisplatin to inhibit bladder cancer cell survival and tumor growth
por: Bhattacharjee, Sayani, et al.
Publicado: (2022)

Inactivation of Pol θ and C-NHEJ eliminates off-target integration of exogenous DNA
por: Zelensky, Alex N., et al.
Publicado: (2017)

Molecular basis of microhomology-mediated end-joining by purified full-length Polθ
por: Black, Samuel J., et al.
Publicado: (2019)

Genetic separation of Brca1 functions reveal mutation-dependent Polθ vulnerabilities
por: Krais, John J., et al.
Publicado: (2023)

Sulforaphane regulates apoptosis- and proliferation-related signaling pathways and synergizes with cisplatin to suppress human ovarian cancer
por: Kan, Shi-Feng, et al.
Publicado: (2018)

The ferroptosis inducer erastin irreversibly inhibits system x(c)− and synergizes with cisplatin to increase cisplatin’s cytotoxicity in cancer cells
por: Sato, Mami, et al.
Publicado: (2018)

Inhibition of DNA-PK by gefitinib causes synergism between gefitinib and cisplatin in NSCLC
por: Pan, Chi, et al.
Publicado: (2020)

Cyclin-dependent kinase inhibitor dinaciclib potently synergizes with cisplatin in preclinical models of ovarian cancer
por: Chen, Xiu-Xiu, et al.
Publicado: (2015)

PD-1 blockade synergizes with oxaliplatin-based, but not cisplatin-based, chemotherapy of gastric cancer
por: Liu, Peng, et al.
Publicado: (2022)

Excess Polθ functions in response to replicative stress in homologous recombination-proficient cancer cells
por: de Rugy, T. Goullet, et al.
Publicado: (2016)

Polθ promotes the repair of 5′-DNA-protein crosslinks by microhomology-mediated end-joining
por: Chandramouly, Gurushankar, et al.
Publicado: (2021)

Polθ inhibitors elicit BRCA-gene synthetic lethality and target PARP inhibitor resistance
por: Zatreanu, Diana, et al.
Publicado: (2021)

Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models
por: Rodriguez-Berriguete, Gonzalo, et al.
Publicado: (2023)

Novobiocin blocks nucleic acid binding to Polθ and inhibits stimulation of its ATPase activity
por: Syed, Aleem, et al.
Publicado: (2023)

Clarithromycin synergizes with cisplatin to inhibit ovarian cancer growth in vitro and in vivo
por: Zhou, Bo, et al.
Publicado: (2019)

Cisplatin, glutathione and the third wheel: a copper-(1,10-phenanthroline) complex modulates cisplatin–GSH interactions from antagonism to synergism in cancer cells resistant to cisplatin
por: Vascellari, Sarah, et al.
Publicado: (2019)

Manganese-deposited iron oxide promotes tumor-responsive ferroptosis that synergizes the apoptosis of cisplatin
por: Cheng, Junjie, et al.
Publicado: (2021)

Isoalantolactone Suppresses Glycolysis and Resensitizes Cisplatin-Based Chemotherapy in Cisplatin-Resistant Ovarian Cancer Cells
por: Chun, Jaemoo
Publicado: (2023)

Synergism of ursolic acid and cisplatin promotes apoptosis and enhances growth inhibition of cervical cancer cells via suppressing NF-κB p65
por: Li, Lan, et al.
Publicado: (2017)

Rapamycin Synergizes with Cisplatin in Antiendometrial Cancer Activation by Improving IL-27–Stimulated Cytotoxicity of NK Cells
por: Zhou, Wen-Jie, et al.
Publicado: (2017)

Morphine, a potential antagonist of cisplatin cytotoxicity, inhibits cisplatin-induced apoptosis and suppression of tumor growth in nasopharyngeal carcinoma xenografts
por: Cao, Long-Hui, et al.
Publicado: (2016)

Publisher Correction: Molecular basis of microhomology-mediated end-joining by purified full-length Polθ
por: Black, Samuel J., et al.
Publicado: (2020)

Synergic Effect of α-Mangostin on the Cytotoxicity of Cisplatin in a Cervical Cancer Model
por: Pérez-Rojas, Jazmin M., et al.
Publicado: (2016)

Combinatorial PD-1 Blockade and CD137 Activation Has Therapeutic Efficacy in Murine Cancer Models and Synergizes with Cisplatin
por: Wei, Huafeng, et al.
Publicado: (2013)

Emetine Synergizes with Cisplatin to Enhance Anti-Cancer Efficacy against Lung Cancer Cells
por: Wu, Ti-Hui, et al.
Publicado: (2019)

Prexasertib (LY2606368) reduces clonogenic survival by inducing apoptosis in primary patient‐derived osteosarcoma cells and synergizes with cisplatin and talazoparib
por: Heidler, Christopher L., et al.
Publicado: (2019)

Deregulation of Exo70 Facilitates Innate and Acquired Cisplatin Resistance in Epithelial Ovarian Cancer by Promoting Cisplatin Efflux
por: Zhao, Yujie, et al.
Publicado: (2021)

Small Molecules Targeting DNA Polymerase Theta (POLθ) as Promising Synthetic Lethal Agents for Precision Cancer Therapy
por: Pismataro, Maria Chiara, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_odc8nfjqm92tv7j7op0a5in6tg